Advertisement
Screener

Lantheus Holdings, Inc. (LNTH) ROE

Lantheus Holdings, Inc. (LNTH) ROE

  • 2026-06-30: ROE 20.99%.
  • 2026-03-31: ROE 23.02%.
  • 2025-12-31: ROE 21.43%.
  • 2025-09-30: ROE 14.98%.

Complete source-backed roe history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3020.99%
2026-03-3123.02%
2025-12-3121.43%
2025-09-3014.98%
2025-06-3023.23%
2025-03-3121.85%
2024-12-3128.72%
2024-09-3036.25%
2024-06-3041.73%
2024-03-3148.71%
2023-12-3140.04%
2023-09-3014.90%
2023-06-306.04%
2023-03-31-3.97%
2022-12-316.28%
2022-09-3016.78%
2022-06-305.71%
2022-03-31-7.24%
2021-12-31-15.35%
2021-09-30-6.90%
2021-06-30-5.40%
2021-03-31-1.48%
2020-12-31-2.62%
2020-09-300.08%
2020-06-302.26%
2020-03-3121.16%
2019-12-3127.63%

Annual ROE

DateROE
2025-12-3121.43%
2024-12-3128.72%
2023-12-3140.04%
2022-12-316.28%
2021-12-31-15.35%
2020-12-31-2.62%
2019-12-3127.63%
2018-12-3157.07%
2017-12-31529.75%

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B